EVH
Evolent Health, Inc. Healthcare - Health Information Services Investor Relations →
Evolent Health, Inc. (EVH) closed at $2.58 as of 2026-03-20, trading 88.2% below its 200-week moving average of $21.83. This places EVH in the extreme value zone. The stock is currently moving closer to the line, down from -86.4% last week. With a 14-week RSI of 29, EVH is in oversold territory.
Trading volume is running at 1.2x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.97 ratio) is neutral — neither side is clearly dominating.
Over the past 515 weeks of data, EVH has crossed below its 200-week moving average 7 times. On average, these episodes lasted 34 weeks. The average one-year return after crossing below was -12.0%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $288 million, EVH is a small-cap stock. The company generates a free cash flow yield of 34.2%, which is notably high. Return on equity stands at -66.5%. The stock trades at 0.7x book value.
Share count has increased 11.7% over three years, indicating dilution. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 9.9 years, a hypothetical investment of $100 in EVH would have grown to $17, compared to $364 for the S&P 500. EVH has returned -16.5% annualized vs 13.9% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: EVH vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After EVH Crosses Below the Line?
Across 7 historical episodes, buying EVH when it crossed below its 200-week moving average produced an average return of -18.7% after 12 months (median -42.0%), compared to +20.1% for the S&P 500 over the same periods. 29% of those episodes were profitable after one year. After 24 months, the average return was -3.8% vs +34.2% for the index.
Each line shows $100 invested at the moment EVH crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
EVH has crossed below its 200-week MA 7 times with an average 1-year return of +-12.0% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 2016 | May 2016 | 2 | 13.5% | +96.6% | -79.8% |
| Dec 2016 | Jan 2017 | 5 | 12.9% | -21.0% | -84.3% |
| Aug 2017 | May 2018 | 39 | 39.0% | +19.3% | -86.0% |
| Dec 2018 | Dec 2018 | 1 | 3.4% | -57.9% | -85.6% |
| Jan 2019 | Nov 2020 | 98 | 71.5% | -45.7% | -85.9% |
| May 2024 | Aug 2024 | 14 | 27.8% | -63.0% | -89.5% |
| Sep 2024 | Ongoing | 77+ | 88.2% | Ongoing | -90.2% |
| Average | 34 | — | +-12.0% | — |
Frequently Asked Questions
Is EVH below its 200-week moving average?
Yes. As of 2026-03-20, Evolent Health, Inc. (EVH) is trading 88.2% below its 200-week moving average of $21.83. The current price is $2.58.
What is EVH's 200-week moving average price?
Evolent Health, Inc.'s 200-week moving average is $21.83 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when EVH drops below its 200-week moving average?
EVH has crossed below its 200-week moving average 7 times in our data. The average one-year return after these crossings was -12.0%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 34 weeks on average.
Is EVH a good value right now?
Here's what our data says about EVH as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 29 (oversold). Free cash flow yield is 34.2%. Return on equity is -66.5%. Price-to-book is 0.7x. This is not a buy or sell recommendation — always do your own research.
How does EVH compare to the S&P 500?
Over the past 9.9 years, $100 invested in EVH would have grown to $17, compared to $364 for the S&P 500. That's -16.5% annualized vs 13.9% for the index. EVH has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20